{"id":1382,"date":"2022-09-21T09:37:03","date_gmt":"2022-09-21T07:37:03","guid":{"rendered":"https:\/\/labolifeint.ditsmarketing.com\/vademecum\/"},"modified":"2025-06-16T08:24:18","modified_gmt":"2025-06-16T06:24:18","slug":"praeparate","status":"publish","type":"page","link":"https:\/\/med.labolife.com\/de\/praeparate\/","title":{"rendered":"Pr\u00e4parate"},"content":{"rendered":"<section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><h1 class=\"w-post-elm post_title entry-title color_link_inherit\">Pr\u00e4parate<\/h1><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_b9d1d30d height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_middle type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"g-cols wpb_row us_custom_ccd693d8 via_flex valign_middle type_default stacking_default\"><div class=\"vc_col-sm-4 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-ibanner animation_phorcys ratio_3x4 easing_ease\"><div class=\"w-ibanner-h\"><div class=\"w-ibanner-image\" style=\"background-image: url(https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Captura-de-pantalla-2023-02-21-a-las-15.35.34.png)\"><\/div><div class=\"w-ibanner-content\"><div class=\"w-ibanner-content-h\"><h6 class=\"w-ibanner-title\">Pr\u00e4parateverzeichnis<\/h6><div class=\"w-ibanner-desc\"><\/div><\/div><\/div><\/div><a target=\"_blank\" href=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Praparateverzeichnis.pdf\" rel=\"noopener\" aria-label=\"Pr\u00e4parateverzeichnis\"><\/a><\/div><\/div><\/div><\/div><div class=\"vc_col-sm-4 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-ibanner animation_phorcys ratio_3x4 easing_ease\"><div class=\"w-ibanner-h\"><div class=\"w-ibanner-image\" style=\"background-image: url(https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Captura-de-pantalla-2023-02-21-a-las-14.45.25.png)\"><\/div><div class=\"w-ibanner-content\"><div class=\"w-ibanner-content-h\"><h6 class=\"w-ibanner-title\">Bestellhilfe<\/h6><div class=\"w-ibanner-desc\"><\/div><\/div><\/div><\/div><a target=\"_blank\" href=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/02\/Bestellhilfe.pdf\" rel=\"noopener\" aria-label=\"Bestellhilfe\"><\/a><\/div><\/div><\/div><\/div><div class=\"vc_col-sm-4 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><div class=\"w-ibanner animation_phorcys ratio_3x4 easing_ease\"><div class=\"w-ibanner-h\"><div class=\"w-ibanner-image\" style=\"background-image: url(https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/01\/Captura-de-pantalla-2024-01-09-a-las-11.48.39.png)\"><\/div><div class=\"w-ibanner-content\"><div class=\"w-ibanner-content-h\"><h6 class=\"w-ibanner-title\">Einnahme der Medikamente<\/h6><div class=\"w-ibanner-desc\"><\/div><\/div><\/div><\/div><a target=\"_blank\" href=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/01\/Einnahme-Flyer_Apotheken_web.pdf\" rel=\"noopener\" aria-label=\"Einnahme der Medikamente\"><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_flex valign_top type_default stacking_default\"><div class=\"vc_col-sm-12 wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\"><h4 class=\"w-text\"><span class=\"w-text-h\"><span class=\"w-text-value\">W\u00e4hlen Sie ein Medikament aus, um dessen Zusammensetzung und Eigenschaften einzusehen.<\/span><\/span><\/h4><div class=\"w-separator size_small\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p>Die Umgestaltung der Verpackungen unserer Medikamente wird mehrere Monate lang andauern und <a href=\"https:\/\/www.labolife.com\/de\/neues-packungsdesign-unserer-medikamente\/\" target=\"_blank\" rel=\"noopener\">stufenhaft erfolgen<\/a>, so dass es m\u00f6glich ist, dass \u00fcbergangsweise zwei verschiedene Verpackungen auf dem Markt sein werden: die alte sowie die neue Verpackung.<\/p>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"w-grid type_grid layout_677 cols_2 popup_page\" id=\"us_grid_1\" data-filterable=\"true\"><style>#us_grid_1 .w-grid-item{padding:0.5rem}#us_grid_1 .w-grid-list{margin:-0.5rem -0.5rem 0.5rem}.w-grid + #us_grid_1 .w-grid-list,.w-grid-none + #us_grid_1 .w-grid-list{margin-top:0.5rem}@media (max-width:956px){#us_grid_1 .w-grid-list{margin:0}#us_grid_1 .w-grid-item{width:100%;padding:0;margin-bottom:0.5rem}}@media (max-width:599px){#us_grid_1 .w-grid-list{margin:0}#us_grid_1 .w-grid-item{width:100%;padding:0;margin-bottom:0.5rem}}.layout_677 .w-grid-item-h{border-radius:2.3rem;box-shadow:0 0rem 0rem rgba(0,0,0,0.1),0 0rem 0rem rgba(0,0,0,0.1);transition-duration:0.3s}.no-touch .layout_677 .w-grid-item-h:hover{box-shadow:0 0.08rem 0.16rem rgba(0,0,0,0.1),0 0.27rem 0.8rem rgba(0,0,0,0.15);z-index:4}.layout_677 .usg_post_title_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_1{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_hwrapper_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_hwrapper_1{transform:scale(1) translate(0%,0%);opacity:1;background:var(--color-alt-content-primary)!important;color:var(--color-header-middle-bg)!important}.layout_677 .usg_post_content_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_content_1{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_1{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_1{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_2{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_2{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_2{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_2{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_3{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_3{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_3{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_3{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_4{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_4{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_4{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_4{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_5{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_5{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_5{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_5{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_6{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_6{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_6{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_6{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_7{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_title_7{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_custom_field_7{transition-duration:0.3s;transform-origin:50% 50%;transform:scale(1) translate(0%,0%)}.layout_677 .w-grid-item-h:hover .usg_post_custom_field_7{transform:scale(1) translate(0%,0%);opacity:1;color:var(--color-content-secondary)!important}.layout_677 .usg_post_title_1{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_hwrapper_1{color:var(--color-header-middle-bg)!important;border-radius:45px!important;border-right-width:1px!important;border-color:var(--color-header-middle-bg)!important;position:relative!important;animation-name:fade!important;animation-delay:0.2!important;border-right-style:solid!important;background:var(--color-content-secondary)!important}.layout_677 .usg_post_image_1{min-width:245px!important;min-height:160px!important;background:var(--color-header-middle-bg)!important}.layout_677 .usg_post_content_1{font-size:10px!important;line-height:13px!important}.layout_677 .usg_hwrapper_2{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_custom_field_1{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_3{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_2{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_2{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_4{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_3{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_3{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_5{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_4{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_4{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_6{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_5{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_5{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_7{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_6{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_6{font-family:var(--font-h1)!important}.layout_677 .usg_hwrapper_8{padding-top:10px!important;padding-right:20px!important}.layout_677 .usg_post_title_7{color:var(--color-alt-content-primary)!important;font-size:20px!important;line-height:22px!important;font-family:var(--font-h1)!important;font-weight:700!important}.layout_677 .usg_post_custom_field_7{font-family:var(--font-h1)!important}@media (min-width:1025px) and (max-width:1280px){.layout_677 .usg_post_image_1{min-width:245px!important;min-height:160px!important}}@media (min-width:601px) and (max-width:1024px){.layout_677 .usg_post_image_1{min-width:245px!important;min-height:160px!important}}@media (max-width:600px){.layout_677 .usg_post_image_1{min-width:140px!important;min-height:200px!important}}<\/style><div class=\"w-grid-list\">\t<article class=\"w-grid-item size_1x1 post-2074 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2074\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lalerg\/\" rel=\"bookmark\" aria-label=\"2LALERG\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lalerg\/\" aria-label=\"2LALERG\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/05\/1715101_LLB_ALERG_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 119 F1- CNK 1715-101<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C17<br \/>\nInterleukin 4 (IL-4): C17, 27<br \/>\nInterleukin 5 (IL-5): C17<br \/>\nInterleukin 6 (IL-6): C17<br \/>\nInterleukin 10 (IL-10): C17<br \/>\nInterleukin 12 (IL-12): C9<br \/>\nInterleukin 13 (IL-13): C17<br \/>\nTumornekrosefaktor Alpha (TNF-a): C17<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C5<br \/>\nPulmin-Histaminum: C15<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-ALERG ref. 2LALERG<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Allergien.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2078 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2078\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2larth\/\" rel=\"bookmark\" aria-label=\"2LARTH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2larth\/\" aria-label=\"2LARTH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591353_LLB_ARTH_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 36 F1 &#8211; CNK 1591-353<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C10, 17<br \/>\nInterleukin 2 (IL-2): C10, 12<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 17<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-ARTH: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-ARTH ref. 2LARTH<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei akuten oder subakuten Entz\u00fcndungssch\u00fcben.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2083 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2083\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lc1\/\" rel=\"bookmark\" aria-label=\"2LC1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lc1\/\" aria-label=\"2LC1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591072_LLB_C1_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 2 F1- CNK 1591-072<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C6, 10<br \/>\nInterleukin 2 (IL-2): C3, 10<br \/>\nInterleukin 4 (IL-4): C6, 10<br \/>\nInterleukin 6 (IL-6): C6, 10<br \/>\nInterleukin 7 (IL-7): C6, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nDimethylsulfoxid (DMSO): C3, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C10, 15<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 30<br \/>\nMolgramostim (GMCSF): C5, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nDesoxyribonukleins\u00e4ure: K10, 12, 30, 200<br \/>\nRibonukleins\u00e4ure: K6, 10, 12, 30, 200<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-C1a: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-C1b: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-C1 ref. 2LC1<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren die immunit\u00e4re Unterst\u00fctzung bei Neoplasien von soliden Tumoren sowie die Unterst\u00fctzung von konventionellen Krebstherapien.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2503\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591072-2LC1.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2087 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2087\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lc1-n\/\" rel=\"bookmark\" aria-label=\"2LC1-N\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lc1-n\/\" aria-label=\"2LC1-N\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_C1-N_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 10 F1 &#8211; CNK 2314-813<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Ribonukleins\u00e4ure: K6, 12, 30, 200<br \/>\nDesoxyribonukleins\u00e4ure: K6, 12, 30, 200<br \/>\nInterferon Alpha (IFN-a): C3<br \/>\nInterferon Gamma (IFN-g): C6<br \/>\nInterleukin 1 (IL-1): C9<br \/>\nInterleukin 2 (IL-2): C3<br \/>\nInterleukin 6 (IL-6): C9<br \/>\nInterleukin 7 (IL-7): C4<br \/>\nInterleukin 10 (IL-10): C27<br \/>\nInterleukin 12 (IL-12): C4<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C27<br \/>\nBasic Fibroblast Growth Factor (bFGF): C27<br \/>\nInsulin Growth Factor 1 (IGF-1): C27<br \/>\nEpidermal Growth Factor (EGF): C27<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-C1a01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-C1b01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-C1c01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLAI-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLAII-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cum cytokinae et SNA\u00ae-C1-N Ref. 2LC1-N<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung im Bereich der Onkologie, im Zusammenhang mit soliden Tumoren.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2622\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2314813-2LC1-N.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2091 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2091\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lc2\/\" rel=\"bookmark\" aria-label=\"2LC2\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lc2\/\" aria-label=\"2LC2\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591080_LLB_C2_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 3 F1 &#8211; CNK 1591-080<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C6, 10<br \/>\nInterleukin 2 (IL-2): C3, 10<br \/>\nInterleukin 4 (IL-4): C6, 10<br \/>\nInterleukin 6 (IL-6): C6, 10<br \/>\nInterleukin 7 (IL-7): C6, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nDimethylsulfoxid (DMSO): C3, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C10, 15<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 30<br \/>\nMolgramostim (GMCSF): C5, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-C2: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-C2 ref. 2LC2<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Neoplasien von soliden Tumoren, nach einer vollst\u00e4ndigen Remission von mehr als einem Jahr.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2507\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591080-2LC2.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2095 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2095\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lchla\/\" rel=\"bookmark\" aria-label=\"2LCHLA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lchla\/\" aria-label=\"2LCHLA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_CHLA_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 37 F1 &#8211; CNK 1591-098<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C9, 10<br \/>\nInterleukin 2 (IL-2): C9, 10<br \/>\nInterferon Alpha (IFN-a): C9, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CHLA: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-CHLA ref. 2LCHLA<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Infektionen durch Chlamydia trachomatis.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2099 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2099\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lcl1\/\" rel=\"bookmark\" aria-label=\"2LCL1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lcl1\/\" aria-label=\"2LCL1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591106_LLB_CL1_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 4 F1 &#8211; CNK 1591-106<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C6, 10<br \/>\nInterleukin 2 (IL-2): C9, 10<br \/>\nInterleukin 4 (IL-4): C9, 10<br \/>\nInterleukin 6 (IL-6): C9, 10<br \/>\nInterleukin 7 (IL-7): C6, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nDimethylsulfoxid (DMSO): C3, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C10, 15<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 30<br \/>\nMolgramostim. (GMCSF): C5, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nDesoxyribonukleins\u00e4ure: K10, 12, 30, 200<br \/>\nRibonukleins\u00e4ure: K6, 10, 12, 30, 200<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CL1a: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CL1b: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-CL1 ref. 2LCL1<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren die immunit\u00e4re Unterst\u00fctzung bei malignen H\u00e4mopathien, wie die Chronischen lymphatischen Leuk\u00e4mien, die Akuten lymphoblastischen Leuk\u00e4mien, Morbus-Hodgkin und die Non-Hodgkin-Lymphome, sowie bei konventionellen Krebstherapien.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2515\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591106-2LCL1.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2103 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2103\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lcl2\/\" rel=\"bookmark\" aria-label=\"2LCL2\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lcl2\/\" aria-label=\"2LCL2\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_CL2_2023_gen1-245x160.png\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 5 F1 &#8211; CNK 1591-114<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C6, 10<br \/>\nInterleukin 2 (IL-2): C9, 10<br \/>\nInterleukin 4 (IL-4): C9, 10<br \/>\nInterleukin 6 (IL-6): C9, 10<br \/>\nInterleukin 7 (IL-7): C6, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nDimethylsulfoxid (DMSO): C3, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C10, 15<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 30<br \/>\nMolgramostim. (GMCSF): C5, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CL2: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-CL2 ref. 2LCL2<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei malignen H\u00e4mopathien, wie die Chronischen lymphatischen Leuk\u00e4mien, die Akuten lymphoblastischen Leuk\u00e4mien, Morbus-Hodgkin und die Non-Hodgkin-Lymphome, nach einer vollst\u00e4ndigen Remission von mehr als einem Jahr.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2522\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591114-2LCL2.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2107 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2107\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lclm\/\" rel=\"bookmark\" aria-label=\"2LCLM\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lclm\/\" aria-label=\"2LCLM\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/11\/1591122_LLB_CLM_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 6 F1 &#8211; CNK 1591-122<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C6, 10<br \/>\nInterleukin 2 (IL-2): C9, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nDimethylsulfoxid (DMSO): C3, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C10, 15<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 30<br \/>\nMolgramostim (GMCSF): C10, 17<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nDesoxyribonukleins\u00e4ure: K10, 12, 30, 200<br \/>\nRibonukleins\u00e4ure: K6, 10, 12, 30, 200<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CLMa: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CLMb: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-CLM ref. 2LCLM<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren die immunit\u00e4re Unterst\u00fctzung bei malignen H\u00e4mopathien, wie die Akute myeloische Leuk\u00e4mie oder die Chronische myeloische Leuk\u00e4mie w\u00e4hrend der Akutund\/oder der Erhaltungsphase, sowie die Unterst\u00fctzung von konventionellen Krebstherapien.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2111 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2111\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lcmv\/\" rel=\"bookmark\" aria-label=\"2LCMV\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lcmv\/\" aria-label=\"2LCMV\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_CMV_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 38 F1 &#8211; CNK 1591-130<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C7, 10<br \/>\nInterleukin 2 (IL-2): C7, 10<br \/>\nInterferon Alpha (IFN-a): C7, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-CMV: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-CMV ref. 2LCMV<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Infektionen durch das Cytomegalievirus sowie beim chronischen M\u00fcdigkeitssyndrom vermutlich viralen Ursprungs durch das CMV, im Falle eines \u201cnormalen\u201c oder defizit\u00e4ren Immunzustands.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2530\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591130-2LCMV.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2115 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2115\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2ldep\/\" rel=\"bookmark\" aria-label=\"2LDEP\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2ldep\/\" aria-label=\"2LDEP\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_DEP_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 310 F1 &#8211; CNK 2601-227<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C27<br \/>\nInterleukin 2 (IL-2): C9<br \/>\nInterleukin 4 (IL-4): C5<br \/>\nInterleukin 6 (IL-6): C17<br \/>\nInterleukin 10 (IL-10): C9<br \/>\nInterleukin 12 (IL-12): C17<br \/>\nNeurotrophin 3 (NT3): C4<br \/>\nErythropo\u00efetin (EPO): C4<br \/>\nInterferon gamma (IFN-\u03b3): C27<br \/>\nCorticotropin Releasing Factor (CRF): C27<br \/>\nTumornekrosefaktor alpha (TNF-\u03b1): C27<br \/>\nNeurotrophin 4 (NT4): C4<br \/>\nTransformierender Wachstumsfaktor alpha (TGF-\u03b1): C4<br \/>\nTransformierender Wachstumsfaktor beta (TGF-\u03b2): C4<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-DEPa-02: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-DEPb-02: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-DEPc-02: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-DEP ref. 2LDEP<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Depressionen.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2654\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601227-2LDEP.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2119 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2119\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2ldmla\/\" rel=\"bookmark\" aria-label=\"2LDMLA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2ldmla\/\" aria-label=\"2LDMLA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_DMLA_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 129 F1 &#8211; CNK 2230-837<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Angiogenin: C27<br \/>\nBrain Derived Neurotrophic Factor (BDNF): C5<br \/>\nCiliary Neurotrophic Factor (CNTF): C4<br \/>\nBasic Fibroblast Growth Factor (bFGF): C9<br \/>\nInsulin Growth Factor 1 (IGF-1): C17<br \/>\nInterleukin 1 (IL-1): C17<br \/>\nMacrophage Inflammatory Protein 1 Alpha (MIP-1a): C27<br \/>\nMacrophage Inflammatory Protein 1 Beta (MIP-1b): C27<br \/>\nNervenwachstumsfaktor (NGF): C4<br \/>\nPigment Epithelium Derived Factor (PDEF): C3<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): C9<br \/>\nRantes: C27<br \/>\nSubstanz P: C27<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C9<br \/>\nTumornekrosefaktor Alpha (TNF-a): C17<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-DMLAa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-DMLAb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-DMLA ref. 2LDMLA<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei altersbedingter Makuladegeneration.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2618\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230837-2LDMLA.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2123 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2123\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2leai\/\" rel=\"bookmark\" aria-label=\"2LEAI\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2leai\/\" aria-label=\"2LEAI\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591155_LLB_EAI_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 35 F1 &#8211; CNK 1591-155<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C10, 27<br \/>\nInterleukin 2 (IL-2): C9, 10<br \/>\nInterleukin 5 (IL-5): C9, 10<br \/>\nInterleukin 6 (IL-6): C7, 10<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C9, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 27<br \/>\nProstaglandin E2 (PGE2): C3, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-EAI: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-EAI ref. 2LEAI<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung in allen F\u00e4llen von Immunhyperreaktivit\u00e4t.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2531\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591155-2LEAI.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2127 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2127\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lebv\/\" rel=\"bookmark\" aria-label=\"2LEBV\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lebv\/\" aria-label=\"2LEBV\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB-AMM_EBV_v1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>AMM HO-BE517377 &#8211; CNK 1591-163<\/p>\n<p>Qualitative und quantitative Zusammensetzung<\/p>\n<p>1 Kapsel (mit 380mg Globuli) enth\u00e4lt:<\/p>\n<p>Interleukin 1 (IL-1) 2L\u00ae: C7 oder C10, 0,0038 ml<br \/>\nInterleukin 2 (IL-2) 2L\u00ae: C7 oder C10, 0,0038 ml<br \/>\nDesoxyribonukleins\u00e4ure (DNS) 2L\u00ae: C8 oder C10, 0,0038 ml<br \/>\nRibonukleins\u00e4ure (RNS) 2L\u00ae: C8 oder C10, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II 2L\u00ae: C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-EBV 2L\u00ae: C10 oder C18, 0,0038 ml<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel.<\/p>\n<p>Anwendungsgebiete:<\/p>\n<p>2LEBV\u00ae ist ein hom\u00f6opathisches Arzneimittel, das Inhaltsstoffe enth\u00e4lt,\u00a0die gew\u00f6hnlich in der Mikroimmuntherapie eingesetzt werden. Es wird zur\u00a0Unterst\u00fctzung der Immunregulation bei durch das Epstein-Barr-Virus (EBV) verursachten\u00a0akuten bzw. chronischen Infektionen angewendet, die von einem Arzt\u00a0diagnostiziert und mittels Laboruntersuchungen\u00a0nachgewiesen wurden.<\/p>\n<p>Rezeptpflichtiges Medikament in Belgien.<\/p>\n<p>Dosierung:<\/p>\n<p>Bei chronischer Infektion (chronisches M\u00fcdigkeitssyndrom):\u00a0eine Kapsel pro Tag, morgens auf n\u00fcchternen Magen, unter Einhaltung\u00a0der Nummerierungsreihenfolge der Kapseln von 1 bis 10. Die empfohlene\u00a0Behandlungsdauer betr\u00e4gt 4 bis 6 Monate (mindestens 4 Monate).\u00a0Bei akuter Infektion (Mononukleose):\u00a0eine Kapsel pro Tag, morgens auf n\u00fcchternen Magen, unter Einhaltung\u00a0der Nummerierungsreihenfolge von der Kapseln 1 bis 10. Die empfohlene\u00a0Behandlungsdauer betr\u00e4gt 1 bis 3 Monate und kann bei Bedarf verl\u00e4ngert werden.\u00a0Die Dosierung kann, bis eine Verbesserung der Symptome eintritt, auf zwei\u00a0Kapseln pro Tag erh\u00f6ht werden, wobei ein Abstand zu den Mahlzeiten einzuhalten\u00a0und die Nummerierungsreihenfolge von 1 bis 10 der Kapseln zu beachten ist.\u00a0Die Behandlung kann auch l\u00e4nger fortgef\u00fchrt werden, wenn der Arzt dies f\u00fcr\u00a0notwendig h\u00e4lt.<\/p>\n<p>Darreichungsform<\/p>\n<p>Sublinguale Einnahme.\u00a0Es ist wichtig, sich die Zusammenfassung der Eigenschaften des Produktes\u00a0durchzulesen.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2695\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V5_EBV.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2131 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2131\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2leid\/\" rel=\"bookmark\" aria-label=\"2LEID\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2leid\/\" aria-label=\"2LEID\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_EID_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 34 F1 &#8211; CNK 1591-171<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C5, 10<br \/>\nInterleukin 2 (IL-2): C5, 10<br \/>\nInterleukin 5 (IL-5): C6, 10<br \/>\nInterleukin 6 (IL-6): C6, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 30<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-EID: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-EID ref. 2LEID<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei akuten, chronischen und rezidivierenden Infektionen bei \u201cnormalem\u201c oder defizit\u00e4rem Immunzustand.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2542\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591171-2LEID.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2135 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2135\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2leid-n\/\" rel=\"bookmark\" aria-label=\"2LEID-N\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2leid-n\/\" aria-label=\"2LEID-N\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_EID-N_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 198 F1 &#8211; CNK 2362-119<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C7<br \/>\nInterleukin 2 (IL-2): C5<br \/>\nInterleukin 3 (IL-3): C3<br \/>\nInterleukin 4 (IL-4): C27<br \/>\nInterleukin 6 (IL-6): C6<br \/>\nInterleukin 10 (IL-10): C17<br \/>\nInterleukin 12 (IL-12): C5<br \/>\nInterferon Gamma (IFN-g): C6<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C27, 30<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5<br \/>\nDesoxyribonukleins\u00e4ure: C8<br \/>\nRibonukleins\u00e4ure: C8<br \/>\nMolgramostim (GMCSF): C5<br \/>\nGranulocyt Colony Stimulating Factor (GCSF): C5<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-EIDa-02: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-EIDb-02: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cum cytokinae et SNA\u00ae-EID-N Ref. 2LEID-N<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei akuten, chronischen und rezidivierenden Infektionen, insbesondere im Bereich der HNO-Infektionen, bei defizit\u00e4rem Immunzustand.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2139 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2139\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lha\/\" rel=\"bookmark\" aria-label=\"2LHA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lha\/\" aria-label=\"2LHA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591197_LLB_HA_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 27 F1 &#8211; CNK 1591-197<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 2 (IL-2): C7, 10<br \/>\nInterleukin 6 (IL-6): C9, 10<br \/>\nPhosphor (PHOS): C9, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HA: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-HA ref. 2LHA<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Virushepatitis A.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2143 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2143\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lhc\/\" rel=\"bookmark\" aria-label=\"2LHC\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lhc\/\" aria-label=\"2LHC\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591213_LLB_HC_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 29 F1 &#8211; CNK 1591-213<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 2 (IL-2): C7, 10<br \/>\nInterleukin 6 (IL-6): C9, 10<br \/>\nInterferon Alpha (IFN-a): C4, 10<br \/>\nPhosphor (PHOS): C9, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HC: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-HC ref. 2LHC<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Virushepatitis B, C und D, im Falle eines \u201cnormalen\u201c oder defizit\u00e4ren Immunzustands.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2147 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2147\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lhcx\/\" rel=\"bookmark\" aria-label=\"2LHCX\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lhcx\/\" aria-label=\"2LHCX\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/11\/1591221_LLB_HCX_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 32 F1 &#8211; CNK 1591-221<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C10, 30<br \/>\nInterleukin 2 (IL-2): C10, 27<br \/>\nInterleukin 5 (IL-5): C10, 30<br \/>\nInterleukin 6 (IL-6): C10, 30<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 30<br \/>\nPhosphor (PHOS): C10, 16<br \/>\nRibonukleins\u00e4ure: C8, 10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HCX: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-HCX ref. 2LHCX<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Virushepatitis B, C und D, im Falle einer Immunhyperreaktivit\u00e4t.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2554\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591221-2LHCX.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2151 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2151\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lherp\/\" rel=\"bookmark\" aria-label=\"2LHERP\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lherp\/\" aria-label=\"2LHERP\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/11\/1591254_LLB_HERP_2023_gen4-5-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>AMM HO-BE520542 &#8211; CNK 1591-254<\/p>\n<p>Qualitative und quantitative Zusammensetzung<\/p>\n<p>1 Kapsel (mit 380mg Globuli) enth\u00e4lt:<\/p>\n<p>Desoxyribonukleins\u00e4ure (DNS) 2L\u00ae: C8 oder C10, 0,0038 ml<br \/>\nRibonukleins\u00e4ure (RNS) 2L\u00ae: C8 oder C10, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HER1 2L\u00ae: C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure. SNA\u00ae-HER2 2L\u00ae: C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I 2L\u00ae: C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II 2L\u00ae: C10 oder C18, 0,0038 ml<\/p>\n<p>Die sonstigen Bestandteile sind: Saccharose.<\/p>\n<p>Anwendungsgebiete<\/p>\n<p>2LHERP\u00ae ist ein hom\u00f6opathisches Arzneimittel, das Inhaltsstoffe enth\u00e4lt,\u00a0die gew\u00f6hnlich in der Mikroimmuntherapie eingesetzt werden. Es wird zur\u00a0Unterst\u00fctzung der Immunregulation bei der Behandlung von Herpesinfektionen\u00a0angewendet.<\/p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Rezeptpflichtiges Medikament in Belgien.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>Dosierung:<\/p>\n<p>Erwachsene:\u00a0eine Kapsel pro Tag, morgens auf n\u00fcchternen Magen, unter Einhaltung\u00a0der Nummerierungsreihenfolge der Kapseln von 1 bis 10. Die empfohlene\u00a0Behandlungsdauer betr\u00e4gt 6 Monate (mindestens 4 Monate).\u00a0Kinder und Jugendliche:\u00a0eine Kapsel pro Tag, morgens auf n\u00fcchternen Magen, unter Einhaltung\u00a0der Nummerierungsreihenfolge der Kapseln von 1 bis 10. Die empfohlene\u00a0Behandlungsdauer betr\u00e4gt 6 Monate (mindestens 4 Monate).\u00a0Gelegentlich kann auf \u00e4rztliches Anraten der Rhythmus der Einnahme der\u00a0Kapseln beschleunigt werden, wobei eine zweite Kapsel 15 bis 30\u00a0Minuten vor\u00a0dem Mittagessen einzunehmen ist. Hierbei ist die Nummerierung der Kapseln\u00a0von 1 bis 10 unbedingt zu beachten.<\/p>\n<p>Darreichungsform<\/p>\n<p>Sublinguale Einnahme.\u00a0Es ist wichtig, sich die Zusammenfassung der Eigenschaften des Produktes\u00a0durchzulesen.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2155 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2155\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2linflam\/\" rel=\"bookmark\" aria-label=\"2LINFLAM\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2linflam\/\" aria-label=\"2LINFLAM\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_INFLAM_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 127 F1 &#8211; CNK 2330-579<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C17<br \/>\nInterleukin 1 Ra ( IL-1 Ra): C3<br \/>\nInterleukin 2 (IL-2): C9<br \/>\nInterleukin 4 (IL-4): C7<br \/>\nInterleukin 6 (IL-6): C9<br \/>\nInterleukin 8 (IL-8): C9<br \/>\nInterleukin 10 (IL-10): C4<br \/>\nInterleukin 13 (IL-13): C9<br \/>\nCiliary Neurotrophic Factor (CNTF): C17<br \/>\nLeukemia Inhibitory Factor (LIF): C17<br \/>\nOnkostatin M (OSM): C9<br \/>\nPlateled Derived Growth Factor (PDGF): C5<br \/>\nProstaglandin E2 (PGE2): K200<br \/>\nRantes: C17<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C5<br \/>\nTumornekrosefaktor Alpha (TNF-a): C17<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-INFLAMa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-INFLAMb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-INFLAM ref. 2LINFLAM<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Entz\u00fcndungsvorg\u00e4ngen.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2703\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/INFLAM_BE_V3.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2159 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2159\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lkah\/\" rel=\"bookmark\" aria-label=\"2LKAH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lkah\/\" aria-label=\"2LKAH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/05\/1591262_LLB_KAH_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 24 F1 &#8211; CNK 1591-262<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C6, 10<br \/>\nInterleukin 2 (IL-2): C10, 27<br \/>\nInterleukin 3 (IL-3): C10, 27<br \/>\nInterleukin 5 (IL-5): C10, 27<br \/>\nInterleukin 6 (IL-6): C10, 30<br \/>\nInterferon Alpha (IFN-a): C5, 10<br \/>\nInterferon Gamma (IFN-g): C6, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C10, 15<br \/>\nMolgramostim. (GMCSF): C10, 17<br \/>\nTumornekrosefaktor Alpha (TNF-a): C5, 10<br \/>\nErythropoetin. (EPO): C3, 10<br \/>\nDesoxyribonukleins\u00e4ure: K10, 12, 30, 200<br \/>\nRibonukleins\u00e4ure: K6, 10, 12, 30, 200<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-KAHa: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-KAHb: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-KAH ref. 2LKAH<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den\u00a0Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren die immunit\u00e4re Unterst\u00fctzung bei Multiplen Myelomen (Morbus Kahler) w\u00e4hrend der Akutund\/oder Erhaltungsphase sowie die\u00a0Unterst\u00fctzung von konventionellen Krebstherapien.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2163 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2163\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2llnh1\/\" rel=\"bookmark\" aria-label=\"2LLNH1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2llnh1\/\" aria-label=\"2LLNH1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/3119559_LLB_LNH1_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 151 F1 \u2013 CNK 3119-559<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Plateled Derived Endothelial Cell Growth Factor (PDECGF): C17, 27<br \/>\nFibroblast Growth Factor basic (bFGF): C27<br \/>\nInsulin Growth Factor 1 (IGF1): C27<br \/>\nInterferon alpha (IFN-a): C7<br \/>\nInterferon gamma (INF-g): C6<br \/>\nInterferon Beta (INF-b): C6<br \/>\nInterleukin 1 (IL-1): C9<br \/>\nInterleukin 2 (IL-2): C17<br \/>\nInterleukin 6 (IL-6): C27<br \/>\nInterleukin 7 (IL-7): C27<br \/>\nInterleukin 9 (IL-9): C27<br \/>\nInterleukin 10 (IL-10): C27<br \/>\nInterleukin 12 (IL-12): C9<br \/>\nDesoxyribonukleins\u00e4ure (DNS): K6, 12, 30, 200<br \/>\nRibonukleins\u00e4ure: K6, 12, 30, 200<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-LNH1d-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II 01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-LNH Ia-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-LNH Ib-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-LNH Ic-01: C18<br \/>\nStem Cell Factor (SCF): C27<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-\u03b2): C17<br \/>\nTumor Nekrose Faktor Alpha (TNF-a): C5<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-LNH1 ref. 2LLNH1<br \/>\nDie Anwenungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltssotffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Non-Hodgkin-Lymphomen.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2167 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2167\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lmda\/\" rel=\"bookmark\" aria-label=\"2LMDA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lmda\/\" aria-label=\"2LMDA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2500981_LLB_MdA_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 190 F1 \u2013 CNK 2500-981<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C9<br \/>\nInterleukin 2 (IL-2): C9<br \/>\nInterleukin 6 (IL-6): C7<br \/>\nInterleukin 13 (IL-13): C5<br \/>\nGlial Derived Neurotrophic Factor (GDNF): C5<br \/>\nBrain Derived Neurotrophic Factor (BDNF): C5<br \/>\nCiliar Neurotrophic Factor (CNTF): C4<br \/>\nTumornekrosefaktor Alpha (TNF-a): C9<br \/>\nErythropoietin (EPO): C3<br \/>\nBasic Fibroblast Growth Factor (bFGF): C5<br \/>\nNervenwachstumsfaktor (NGF): C7<br \/>\nInsulin Growth Factor 1 (IGF-1): C4<br \/>\nNeurotrophin 3 (NT3): C5<br \/>\nNeurotrophin 4 (NT4): C5<br \/>\nBeta-N-Methylamino-L-Alanin (bMAA): C27<br \/>\nSubstanz P (Subst. P): C4<br \/>\nNeuropeptid Y (NPY): C7<br \/>\nBeta-Amyloid-Protein (b amyl. Prot.): C9<br \/>\nSomatostatin: C4<br \/>\nDesoxyribonukleins\u00e4ure (DNS): C8<br \/>\nRibonukleins\u00e4ure (RNS): C8<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00aeHLA I: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00aeHLA II: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00aeMdAa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00aeMdAb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MdA ref. 2LMdA<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei den Symptomen der Alzheimer Krankheit.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2171 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2171\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lmem-senior\/\" rel=\"bookmark\" aria-label=\"2LMEM-SENIOR\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lmem-senior\/\" aria-label=\"2LMEM-SENIOR\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_MEM-SENIOR_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 225 F1 &#8211; CNK 2230-829<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C9<br \/>\nInterleukin 2 (IL-2): C17<br \/>\nInterleukin 6 (IL-6): C5<br \/>\nInterleukin 12 (IL-12): C9<br \/>\nInterleukin 13 (IL-13): C4<br \/>\nBrain Derived Neurotrophic Factor (BDNF): C5<br \/>\nCiliary Neurotrophic Factor (CNTF): C4<br \/>\nEpidermal Growth Factor (EGF): C7<br \/>\nErythropoetin (EPO): C4<br \/>\nFibroblast Growth Factor Basic (bFGF): C5<br \/>\nGlial cell-line Derived Neurotrophic Factor (GDNF): C5<br \/>\nInsulin Growth Factor 1 (IGF-1): C7<br \/>\nInterferon Beta (IFN-b): C3<br \/>\nLeukemia Inhibitory Factor (LIF): C5<br \/>\nNervenwachstumsfaktor (NGF): C4<br \/>\nNeurotrophin 3 (NT3): C5<br \/>\nNeurotrophin 4 (NT4): C5<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): C5<br \/>\nPregnenolonsulfat (PREG\u2019S): C3<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C5<br \/>\nTumornekrosefaktor Alpha (TNF-a): C9<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MEM-SENIORa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MEM-SENIORb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MEM-SENIOR ref. 2LMEM-SENIOR<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Pathologien im Zusammenhang mit altersbedingtem Ged\u00e4chtnisverlust.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2614\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230829-2LMEMSENIOR.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2175 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2175\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lmici\/\" rel=\"bookmark\" aria-label=\"2LMICI\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lmici\/\" aria-label=\"2LMICI\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_MICI_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 131 F1 &#8211; CNK 2373-405<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1(IL-1): C27<br \/>\nInterleukin 2 (IL-2): C9<br \/>\nInterleukin 4 (IL-4): C9<br \/>\nInterleukin 6 (IL-6): C9<br \/>\nInterleukin 8 (IL-8): C17<br \/>\nInterleukin 10 (IL10): C5<br \/>\nIL1 Receptor antagonist (IL-1 Ra): C3<br \/>\nInterCellular Adhesion Molecule (ICAM): C27<br \/>\nInterferon Gamma (IFN-g): C17<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C9<br \/>\nTumornekrosefaktor Alpha (TNF-a): C27<br \/>\nProstaglandin E2 (PGE2): K200<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MICIb-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MICIa-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MICI ref. 2LMICI<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Pathologien im Zusammenhang mit chronisch-entz\u00fcndlichen Darmerkrankungen.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2638\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2373405-2LMICI.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2179 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2179\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lmireg\/\" rel=\"bookmark\" aria-label=\"2LMIREG\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lmireg\/\" aria-label=\"2LMIREG\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_MIREG_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 46 F1 &#8211; CNK 1591-270<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C10, 27<br \/>\nInterleukin 2 (IL-2): C10, 27<br \/>\nInterleukin 5 (IL-5): C10, 27<br \/>\nInterleukin 6 (IL-6): C10, 27<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 27<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C10, 15<br \/>\nProstaglandin E2: C3, 10<br \/>\nDesoxyribonukleins\u00e4ure: C10, 18<br \/>\nRibonukleins\u00e4ure: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MIREG: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MIREG ref. 2LMIREG<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei verschiedenen genetischen Erkrankungen.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2562\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591270-2LMIREG.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2183 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2183\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lmisen\/\" rel=\"bookmark\" aria-label=\"2LMISEN\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lmisen\/\" aria-label=\"2LMISEN\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591288_LLB_MISEN_2023_gen2-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 47 F1 &#8211; CNK 1591-288<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 2 (IL-2): C7, 10<br \/>\nEpidermaler Wachstumsfaktor (EGF): C7, 10<br \/>\nDehydroepiandrosteron (DHEA): C3, 10<br \/>\nDimethylsulfoxid (DMSO): C3, 10<br \/>\nRibonukleins\u00e4ure: C9, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MISEN: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-MISEN ref. 2LMISEN<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Stress- und Alterungszust\u00e4nden sowie bei deren Folgeerkrankungen.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2566\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591288-2LMISEN.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2187 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2187\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2losteo-n\/\" rel=\"bookmark\" aria-label=\"2LOSTEO-N\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2losteo-n\/\" aria-label=\"2LOSTEO-N\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_OSTEO-N_2023_gen2_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 207 F1 &#8211; CNK 2209-377<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C17<br \/>\nInterleukin 6 (IL-6): C17<br \/>\nInterleukin 11 (IL-11): C15<br \/>\nBone Morphogenetic Protein-2 (BMP-2): C5<br \/>\nBone Morphogenetic Protein-4 (BMP-4): C5<br \/>\nDesoxyribonukleins\u00e4ure: C5<br \/>\nInsulin Growth Factor 1 (IGF-1): C9<br \/>\nMolgramostim (GMCSF): C15<br \/>\nNatrum Silicofluoricum (Nat.Sil.Fl.): C3<br \/>\nRibonukleins\u00e4ure: C5<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C5<br \/>\nTumornekrosefaktor Alpha (TNF-a): C17<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-OSTEOa-02: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-OSTEOb-02: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-OSTEO-N ref. 2LOSTEO-N<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren die immunit\u00e4re Unterst\u00fctzung bei Knochenbr\u00fcchen und Mangelerscheinungen an den Knochen, wie zum Beispiel altersbedingte Osteoporose und Folgeerscheinungen der Menopause.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2606\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2209377-2LOSTEO-N.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2191 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2191\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lpapi\/\" rel=\"bookmark\" aria-label=\"2LPAPI\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lpapi\/\" aria-label=\"2LPAPI\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/05\/1591296_LLB_PAPI_2023_gen4-5-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>AMM HO-BE508551 &#8211; CNK 1591-296<\/p>\n<p>Qualitative und quantitative Zusammensetzung<\/p>\n<p>1 Kapsel (mit 380mg Globuli) enth\u00e4lt:<\/p>\n<p>Interleukin 1 (IL-1) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nInterleukin 2 (IL-2) 2L\u00ae: C10 oder C17, 0,0038 ml<br \/>\nInterferon alpha (IFN\u03b1) 2L\u00ae: C10 oder C17, 0,0038 ml<br \/>\nCiclosporin A (CsA) 2L\u00ae: C7 oder C10 oder C17, 0,0038 ml<br \/>\nRibonukleins\u00e4ure (RNS) 2L\u00ae: C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II 2L\u00ae: C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-PAPI 2L\u00ae: C10 oder C18, 0,0038 ml<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel.<\/p>\n<p>Anwendungsgebiete<\/p>\n<p>2LPAPI\u00ae ist ein hom\u00f6opathisches Arzneimittel, das Inhaltsstoffe enth\u00e4lt,\u00a0die gew\u00f6hnlich in der Mikroimmuntherapie eingesetzt werden. Es wird zur\u00a0Unterst\u00fctzung der Immunregulation bei durch Humane Papillomaviren verursachten\u00a0anogenitalen Infektionen angewendet, die von einem Arzt diagnostiziert\u00a0und mittels Laboruntersuchungen nachgewiesen wurden.<\/p>\n<p>Rezeptpflichtiges Medikament in Belgien.<\/p>\n<p>Dosierung<\/p>\n<p>Kinder von 0 bis 12 Jahren, Jugendliche von 12 bis 18 Jahren, Erwachsene:<\/p>\n<p>1 Kapsel pro Tag<\/p>\n<p>Wenn nicht anders verordnet, betr\u00e4gt die Behandlungsdauer:<\/p>\n<p>bei einem \u00ablow-risk\u00bb-HPV-Typ<\/p>\n<p>(HPV-Gruppe 3): 4 Monate<\/p>\n<p>bei einem \u00abhigh-risk\u00bb-HPV-Typ<\/p>\n<p>(HPV-Gruppe 1, 2A, 2B) : 6 Monate<\/p>\n<p>Die Behandlung kann auch l\u00e4nger fortgef\u00fchrt werden, wenn der Arzt dies f\u00fcr\u00a0notwendig h\u00e4lt.<\/p>\n<p>2LPAPI\u00ae ersetzt keine HPV-Impfung. Es kann nach der Impfung angewendet\u00a0werden, wenn der Arzt dies f\u00fcr erforderlich erachtet.\u00a0Die Papillomaviren verursachen sexuell \u00fcbertragbare Infektionen. Im Falle einer\u00a0Infektion sollte Geschlechtsverkehr vermieden werden. Es muss immer an geeigneten\u00a0Schutz gedacht werden und der Partner muss bei Bedarf mitbehandelt\u00a0werden.<\/p>\n<p>Darreichungsform<\/p>\n<p>Sublinguale Einnahme.\u00a0Es ist wichtig, sich die Zusammenfassung der Eigenschaften des Produktes\u00a0durchzulesen.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2195 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2195\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lpark\/\" rel=\"bookmark\" aria-label=\"2LPARK\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lpark\/\" aria-label=\"2LPARK\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153_LLB_PARK_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 173 F1- CNK 1785-153<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C17<br \/>\nInterleukin 2 (IL-2): C17<br \/>\nInterleukin 6 (IL-6): C17<br \/>\nInterleukin 12 (IL-12): C17<br \/>\nBrain Derived Neurotrophic Factor (BDNF): C4<br \/>\nBeta N Methyl Amino Alanin (bMAA): C27<br \/>\nCiliar Neurotrophic Factor (CNTF): C4<br \/>\nErythropoetin (EPO): C3<br \/>\nGlial cell-line Derived Neurotrophic Factor (GDNF): C4<br \/>\nInsulin Growth Factor 1 (IGF-1): C4<br \/>\nNeurotensin (NT): C4<br \/>\nNeurotrophin 3 (NT3): C4<br \/>\nPlatelet Derived Endothelial Cell Growth Factor (PDECGF): C4<br \/>\nSomatostatin (SS): C4<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C4<br \/>\nTumornekrosefaktor Alpha (TNF-a): C17<br \/>\nRibonukleins\u00e4ure: C8<br \/>\nDesoxyribonukleins\u00e4ure: C8<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-PARK ref. 2LPARK<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren ein trophischer Beitrag und die immunit\u00e4re Unterst\u00fctzung bei verschiedenen Erkrankungen des zentralen Nervensystems, die zu einer Degeneration der dopaminergischen Neuronen innerhalb des Hirnstamms f\u00fchren, welche die Grundlage der Parkinsonkrankheit darstellt.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2670\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785153-2LPARK.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2199 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2199\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lpr\/\" rel=\"bookmark\" aria-label=\"2LPR\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lpr\/\" aria-label=\"2LPR\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_PR_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 141 F1 \u2013 CNK 2500-999<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C27<br \/>\nInterleukin 2 (IL-2): C17<br \/>\nInterleukin 4 (IL-4): C5<br \/>\nInterleukin 6 (IL-6): C27<br \/>\nInterleukin 8 (IL-8): C27<br \/>\nInterleukin 10 (IL-10): C5<br \/>\nInterleukin 12 (IL-12): C17<br \/>\nInterleukin 13 (IL-13): C4<br \/>\nInterleukin (IL-15): C17<br \/>\nInterferon gamma (INF-g): C17<br \/>\nIL1 Receptor antagonist (IL-1 Ra): C3<br \/>\nAngiogenin: C30<br \/>\nBasic Fibroblast Growth Factor (bFGF): C27<br \/>\nMolgramostim (GMCSF): C27<br \/>\nMonocyt Colony Stimulating (MCSF): C27<br \/>\nPlateled Derived Growth Factor (PDGF): C27<br \/>\nTransformierender Wachstumsfaktor beta (TGF-\u03b2): C7<br \/>\nTumornekrosefaktor alpha (TNF-\u03b1): C27<br \/>\nVascular Endothelial Growth Factor (VEGF): C30<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-PRa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-PRb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-PR ref. 2LPR<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei rheumatoider Arthritis.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2646\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2500999-2LPR.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2203 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2203\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lpso\/\" rel=\"bookmark\" aria-label=\"2LPSO\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lpso\/\" aria-label=\"2LPSO\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/01\/LLB_PSO_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 133 F1 &#8211; CNK 2362-127<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 6 (IL-6): C27<br \/>\nInterleukin 8 (IL-8): C27<br \/>\nInterleukin 10 (IL-10): C5<br \/>\nInterleukin 13 (IL-13): C4<br \/>\nInterleukin 20 (IL-20): C27<br \/>\nTumornekrosefaktor Alpha (TNF-\u03b1): C27<br \/>\nInterferon Gamma (IFN-\u03b3): C27<br \/>\nBasic Fibroblast Growth Factor (bFGF): C27<br \/>\nEpidermaler Wachstumsfaktor (EGF): C27<br \/>\nInsulin Growth Factor 1(IGF-1): C27<br \/>\nKeratinocyt Growth Factor (KGF): C27<br \/>\nTransformierender Wachstumsfaktor Alpha (TGF-\u03b1): C4<br \/>\nVascular Endothelial Growth Factor (VEGF): C27<br \/>\nCiclosporin A (Cy A): C4<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-PSOa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-PSOb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-PSO ref. 2LPSO<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Erkrankungen im Zusammenhang mit Psoriasis.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2634\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2362127-2LPSO.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2207 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2207\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2ls1\/\" rel=\"bookmark\" aria-label=\"2LS1\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2ls1\/\" aria-label=\"2LS1\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591304_LLB_S1_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 25 F1 &#8211; CNK 1591-304<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C5, 10<br \/>\nInterleukin 3 (IL-3): C3, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C9, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 17<br \/>\nCyclosporin A: C5, 10, 17<br \/>\nErythropoetin (EPO): C3, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-S1: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-S1 ref. 2LS1<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei HIV-Infektionen in allen Krankheitsstadien, als Erg\u00e4nzung der \u00fcblichen Therapien.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2574\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591304-2LS1.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2249 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2249\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2ls2\/\" rel=\"bookmark\" aria-label=\"2LS2\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2ls2\/\" aria-label=\"2LS2\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_S2_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 26 F1 &#8211; CNK 1591-312<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C5, 10<br \/>\nInterleukin 3 (IL-3): C3, 10<br \/>\nInterferon Alpha (IFN-a): C3, 10<br \/>\nInterferon Gamma (IFN-g): C9, 10<br \/>\nCyclosporin A: C5, 10, 17<br \/>\nErythropoetin. (EPO): C3, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 17<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-S2: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-S2 ref. 2LS2<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt, erg\u00e4nzend zu 2L S1, die immunit\u00e4re Unterst\u00fctzung beim Auftreten von opportunistischen Infektionen, als Erg\u00e4nzung von konventionellen Therapien der Infektionsbek\u00e4mpfung.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2578\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591312-2LS2.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2212 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2212\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lsen\/\" rel=\"bookmark\" aria-label=\"2LSEN\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lsen\/\" aria-label=\"2LSEN\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_SEN_2023_gen3_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 113 F1 &#8211; CNK 2960-433<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Neurotrophin 3 (NT3): C5<br \/>\nNeurotrophin 4 (NT4): C5<br \/>\nEpidermaler Wachstumsfaktor (EGF): C7<br \/>\nDehydroepiandrosteron (DHEA): C3<br \/>\nFibroblast Growth Factor basic (FGFb): C5<br \/>\nGlial Derived Neurotrophic Factor (GDNF): C5<br \/>\nInsulin Growth Factor 1 (IGF1): C4<br \/>\nInterferon beta (IFN-\u03b2): C7<br \/>\nInterleukin 1 (IL-1): C9<br \/>\nInterleukin 12 (IL-12): C9<br \/>\nInterleukin 13 (IL-13): C7<br \/>\nInterleukin 2 (IL-2): C9<br \/>\nInterleukin 6 (IL-6): C5<br \/>\nCiliary Neuro Trophic Factor (CNTF): C4<br \/>\nNervenwachstumsfaktor (NGF): C4<br \/>\nPlatelet Derived Endothelial Cell Growth Factor (PDECGF): C5<br \/>\nRibonukleins\u00e4ure (RNS): C8<br \/>\nDesoxyribonukleins\u00e4ure (DNS): C8<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C5<br \/>\nTumornekrosefaktor Alpha (TNF-a): C9<br \/>\nLeukemia Inhibitory Factor (LIF): C5<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MISENa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MISENb-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MISENc-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-MISENd-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-SEN ref. 2LSEN<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung im Kontext der Zell- und Gewebealterung und der damit in Verbindung stehenden Erkrankungen.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2658\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2960433-2LSEN.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2216 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2216\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lsep\/\" rel=\"bookmark\" aria-label=\"2LSEP\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lsep\/\" aria-label=\"2LSEP\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1785146_LLB_SEP_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 167 F 1 &#8211; CNK 1785-146<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C9<br \/>\nInterleukin 2 (IL-2): C27<br \/>\nInterleukin 4 (IL-4): C4<br \/>\nInterleukin 6 (IL-6): C17<br \/>\nInterleukin 10 (IL-10): C4<br \/>\nInterleukin 12 (IL-12): C27<br \/>\nInterleukin 13 (IL-13): C17<br \/>\nBasic Fibroblast Growth Factor (bFGF): C4<br \/>\nCiliary Neurotrophic Factor (CNTF): C4<br \/>\nEpidermaler Wachstumsfaktor(EGF): C4<br \/>\nErythropoetin (EPO): C3<br \/>\nGlial cell-line Derived Neurotrophic Factor (GDNF): C4<br \/>\nInterferon Beta 1-a (IFN b-1a): C3<br \/>\nInterferon Gamma (IFN-g): C27<br \/>\nInsulin Growth Factor 1 (IGF-1): C4<br \/>\nMakrophagen inflammatorisches Protein 1 Aplha (MIP-1a): C27<br \/>\nNervenwachstumsfaktor (NGF): C4<br \/>\nNeutrophin 3 (NT3): C4<br \/>\nPlatelet Derived Endothelial Cell Growth Factor (PDECGF): C4<br \/>\nRantes: C27<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C4<br \/>\nTumornekrosefaktor Alpha (TNF-a): C17<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-SEPa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-SEPb-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-SEPc-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-SEP ref. 2LSEP<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6ren ein trophischer Beitrag und die immunit\u00e4re Unterst\u00fctzung bei demyelisierenden Erkrankungen im Bereich des zentralen Nervensystems, wie zum Beispiel die Multiple Sklerose.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2598\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1785146-2LSEP.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2220 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2220\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lsleepreg\/\" rel=\"bookmark\" aria-label=\"2LSLEEPREG\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lsleepreg\/\" aria-label=\"2LSLEEPREG\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/2230811_LLB_SLEEPREG_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 318 F1 &#8211; CNK 2230-811<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 4 (IL-4): C27<br \/>\nInterleukin 6 (IL-6): C4<br \/>\nInterleukin 10 (IL-10): C27<br \/>\nInterleukin 13 (IL-13): C27<br \/>\nInterleukin 1 Beta (IL-1b): C4<br \/>\nBrain Derived Neurotrophic Factor (BDNF): K12, 30<br \/>\nBeta Endorphin (b-Endorphin): C9<br \/>\nIL1 Rezeptorantagonist (IL-1Ra): C27<br \/>\nInterferon Beta (IFN-b): C4<br \/>\nNervenwachstumsfaktor (NGF): K12, 30<br \/>\nTumornekrosefaktor Alpha (TNF-a): C4<br \/>\nVasoactive Intestinal Peptide (VIP): C4<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-SLEEPREGa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-SLEEPREGb-01: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-SLEEPREG ref. 2LSLEEPREG<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung im Zusammenhang mit Schlafst\u00f6rungen sowie der Schlafregulierung und dem Einschlafen.<\/p>\n<p>Die Einnahme der Globuli erfolgt vor dem Schlafengehen und mindestens eine Stunde nach dem Abendessen.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2608\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2230811-2LSLEEPREG.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2224 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2224\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2ltnm\/\" rel=\"bookmark\" aria-label=\"2LTNM\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2ltnm\/\" aria-label=\"2LTNM\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/2601193_LLB_TNM_2023_gen3-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 192 F1 \u2013 CNK 2601-193<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 6 (IL-6): C27<br \/>\nInterleukin 12 (IL-12): C4<br \/>\nInterferon Alpha (INF-a): C3<br \/>\nRibonukleins\u00e4ure (RNS): K6, 12, 30, 200<br \/>\nCiliary Neurotrophic Factor (CNTF): C27<br \/>\nDesoxyribonukleins\u00e4ure (DNS): K6, 12, 30, 200<br \/>\nEpidermal Growth Factor (EGF): C27<br \/>\nInsulin Growth Factor 1 (IGF-1): C27<br \/>\nAngiogenin: C27<br \/>\nPlateled Derived Endothelial Cell Growth Factor (PDECGF): C7<br \/>\nSomatostatin (S.S): C27<br \/>\nTransformierender Wachstumsfaktor Beta (TGF-b): C27<br \/>\nTumornekrosefaktor Alpha (TNF-a): C7<br \/>\nVascular Endothelial Growth Factor (VEGF): C27<br \/>\nLeukemia Inhibitory Factor (LIF): C9<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-TNMa-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-TNMb-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-TNMc-01: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-TNM ref. 2LTNM<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei malignen neurologischen Tumoren (Gehirntumoren).<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2647\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/2601193-2LTNM.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2228 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2228\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2ltoxo\/\" rel=\"bookmark\" aria-label=\"2LTOXO\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2ltoxo\/\" aria-label=\"2LTOXO\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/1591320_LLB_TOXO_2023_gen3-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 42 F1- CNK 1591-320<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C7, 10<br \/>\nInterleukin 2 (IL-2): C7, 10<br \/>\nInterferon Gamma (IFN-g): C7, 10<br \/>\nTumornekrosefaktor Alpha (TNF-a): C7, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-TOXO: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-TOXO ref. 2LTOXO<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Infektionen durch Toxoplasma Gondii sowie beim chronischen M\u00fcdigkeitssyndrom vermutlich parasit\u00e4ren Ursprungs.<\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2234 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2234\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lveru\/\" rel=\"bookmark\" aria-label=\"2LVERU\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lveru\/\" aria-label=\"2LVERU\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/1591338_LLB_VERU_2023_gen4-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>AMM HO-BE508533 &#8211; CNK 1591-338<\/p>\n<p>Qualitative und quantitative Zusammensetzung<\/p>\n<p>1 Kapsel (mit 380mg Globuli) enth\u00e4lt:<\/p>\n<p>Interleukin 1 (IL-1) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nInterleukin 2 (IL-2) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nInterferon alpha (IFN\u03b1) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nRibonukleins\u00e4ure (RNS) 2L\u00ae : C8 oder C10, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II 2L\u00ae : C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-VERU 2L\u00ae : C10 oder C18, 0,0038 ml<\/p>\n<p>Die sonstigen Bestandteile sind: Saccharose<\/p>\n<p>Anwendungsgebiete<\/p>\n<p>2LVERU\u00ae ist ein hom\u00f6opathisches Arzneimittel, das Inhaltsstoffe enth\u00e4lt,\u00a0die gew\u00f6hnlich in der Mikroimmuntherapie eingesetzt werden. Es wird zur\u00a0Unterst\u00fctzung der Immunregulation bei der Behandlung gew\u00f6hnlicher Warzen\u00a0(verruca vulgaris), flacher Warzen (verruca plana) bzw. von Plantarwarzen\u00a0(verruca plantaris) angewendet.<\/p>\n<p>Dosierung<\/p>\n<p>Erwachsene, Jugendliche von 12 bis 18 Jahren.\u00a0Wenn nicht anders verordnet, betr\u00e4gt die Behandlungsdauer:\u00a0eine Kapsel pro Tag, morgens auf n\u00fcchternen Magen, unter Einhaltung\u00a0der Nummerierungsreihenfolge der Kapseln von 1 bis 10. Die empfohlene\u00a0Behandlungsdauer betr\u00e4gt 4 bis 6 Monate (bzw. bis zum Verschwinden der\u00a0Warzen).<\/p>\n<p>Darreichungsform<\/p>\n<p>Sublinguale Einnahme.\u00a0Es ist wichtig, sich die Zusammenfassung der Eigenschaften des Produktes\u00a0durchzulesen.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-1831\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/2LVERU-NUEVO.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2238 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2238\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lveru-junior\/\" rel=\"bookmark\" aria-label=\"2LVERU-JUNIOR\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lveru-junior\/\" aria-label=\"2LVERU-JUNIOR\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2025\/09\/3595600_LLB_VERUJUNIOR_2023_gen4-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>AMM HO-BE508542 &#8211; CNK 3595-600<\/p>\n<p>Qualitative und quantitative Zusammensetzung<\/p>\n<p>1 Kapsel (mit 380mg Globuli) enth\u00e4lt:<\/p>\n<p>Interleukin 1 (IL-1) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nInterleukin 2 (IL-2) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nInterferon alpha (IFN\u03b1) 2L\u00ae : C10 oder C17, 0,0038 ml<br \/>\nRibonukleins\u00e4ure (RNS) 2L\u00ae : C8 oder C10, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II 2L\u00ae : C10 oder C18, 0,0038 ml<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-VERU 2L\u00ae : C10 oder C18, 0,0038 ml<\/p>\n<p>Die sonstigen Bestandteile sind: Saccharose.<\/p>\n<p>Anwendungsgebiete:<br \/>\n2LVERU\u00ae JUNIOR ist ein hom\u00f6opathisches Arzneimittel, das Inhaltsstoffe enth\u00e4lt,\u00a0die gew\u00f6hnlich in der Mikroimmuntherapie eingesetzt werden. Es wird zur\u00a0Unterst\u00fctzung der Immunregulation bei der Behandlung gew\u00f6hnlicher Warzen\u00a0(verruca vulgaris), flacher Warzen (verruca plana) bzw. von Plantarwarzen\u00a0(verruca plantaris) angewendet.<\/p>\n<p>Rezeptpflichtiges Medikament in Belgien.<\/p>\n<p>Dosierung:<br \/>\nKinder von 3 bis 12 Jahren<br \/>\nWenn nicht anders verordnet, betr\u00e4gt die Behandlungsdauer:\u00a0eine Kapsel pro Tag, morgens auf n\u00fcchternen Magen, unter Einhaltung\u00a0der Nummerierungsreihenfolge der Kapseln von 1 bis 10. Die empfohlene\u00a0Behandlungsdauer betr\u00e4gt 4 bis 6 Monate (bzw. bis zum Verschwinden der\u00a0Warzen).<\/p>\n<p>Darreichungsform:<\/p>\n<p>Sublinguale Einnahme<\/p>\n<p>Es ist wichtig, sich die Zusammenfassung der Eigenschaften des Produktes\u00a0durchzulesen.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2689\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/AMM_BE_V4_VERUJUNIOR.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2242 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2242\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lxfs\/\" rel=\"bookmark\" aria-label=\"2LXFS\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lxfs\/\" aria-label=\"2LXFS\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_XFS_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 44 F1 &#8211; CNK 1591-346<br \/>\nZusammensetzung entsprechend einer Sequenz von 10 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 1 (IL-1): C10, 12<br \/>\nInterleukin 2 (IL-2): C10, 12<br \/>\nInterferon Alpha (IFN-a): D6, 10<br \/>\nInterferon Gamma (IFN-g): C10, 17<br \/>\nTumornekrosefaktor Alpha (TNF-a): C10, 17<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10 und K10, 30<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-XFSa: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-XFSb: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-XFSc: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-XFS ref. 2LXFS<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei chronischen Infektionen, verursacht im Allgemeinen durch das Epstein-Barr-Virus, das Cytomegalievirus oder Toxoplasma Gondii, sowie beim chronischen M\u00fcdigkeitssyndrom oft viralen oder parasit\u00e4ren Ursprungs, im Falle einer Immunhyperreaktivit\u00e4t.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2590\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-300x169.png\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-300x169.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-1024x576.png 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-150x84.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol-70x39.png 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591346-2LXFS_surSol.png 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-2246 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"2246\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/2lzona\/\" rel=\"bookmark\" aria-label=\"2LZONA\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/2lzona\/\" aria-label=\"2LZONA\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/12\/LLB_ZONA_2023_gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><p>1507 CH 45 F1 &#8211; CNK 1591-064<br \/>\nZusammensetzung entsprechend einer Sequenz von 5 Kapseln:<br \/>\nFormel:<\/p>\n<p>Interleukin 2 (IL-2): C7, 10<br \/>\nInterferon Alpha (IFN-a): C7, 10<br \/>\nDesoxyribonukleins\u00e4ure: C8, 10<br \/>\nRibonukleins\u00e4ure: C8, 10<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA I: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-HLA II: C10, 18<br \/>\nSpezifische Nukleins\u00e4ure SNA\u00ae-ZONA: C10, 18<\/p>\n<p>Tr\u00e4gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<p>Compositio cytokinae et SNA\u00ae-ZONA ref. 2LZONA<br \/>\nDie Anwendungsgebiete leiten sich von den Eigenschaften und den Verd\u00fcnnungsstufen der Inhaltsstoffe ab. Dazu geh\u00f6rt die immunit\u00e4re Unterst\u00fctzung bei Virusinfektionen durch Herpes Zoster.<\/p>\n<p>Der Wechsel des Packungsdesigns wird mehrere Monate dauern und schrittweise erfolgen, so dass es m\u00f6glich ist, dass f\u00fcr einige Zeit zwei verschiedene Verpackungen desselben Produktes auf dem Markt sein werden: die neue und die alte.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-2502\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-300x169.jpg\" alt=\"\" width=\"300\" height=\"169\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-300x169.jpg 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-1024x576.jpg 1024w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-150x84.jpg 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA-70x39.jpg 70w, https:\/\/med.labolife.com\/wp-content\/uploads\/2023\/01\/1591064-2LZONA.jpg 1920w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4087 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4087\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/bmp-2-5ch\/\" rel=\"bookmark\" aria-label=\"BMP-2 5CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/bmp-2-5ch\/\" aria-label=\"BMP-2 5CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/2730224_LLB_BMP2-5CH_2023-gen1-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 106 F33 \u2013 CNK 2730-224<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bone Morphogenetic Protein-2 (BMP-2) 5CH<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Tra\u0308gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4091 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4091\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/bmp-4-5ch\/\" rel=\"bookmark\" aria-label=\"BMP-4 5CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/bmp-4-5ch\/\" aria-label=\"BMP-4 5CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/2730216_LLB_BMP4-5CH_2023-gen1-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 107 F33\u2013 CNK 2730-216<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Bone Morphogenetic Protein-4 (BMP-4) 5CH<\/p>\n<div class=\"page\" title=\"Page 78\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Tra\u0308gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4103 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4103\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/il-1-27ch\/\" rel=\"bookmark\" aria-label=\"IL-1 27CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/il-1-27ch\/\" aria-label=\"IL-1 27CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/3710928_LLB_IL1-27CH_2023-gen1-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 79\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 31 F33 \u2013 CNK &#8211; 3710-928<\/p>\n<div class=\"page\" title=\"Page 79\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Interleukin 1 (IL-1) 27CH<\/p>\n<p>Tra\u0308gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4107 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4107\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/il-2-4ch\/\" rel=\"bookmark\" aria-label=\"IL-2 4CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/il-2-4ch\/\" aria-label=\"IL-2 4CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/LLB_IL2-4CH_2023-gen1_web-245x160.jpg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 34 F33\u2013 CNK &#8211; 3709-847<\/p>\n<div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Interleukin 2 (IL-2) 4CH<\/p>\n<p>Tra\u0308gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n\t<article class=\"w-grid-item size_1x1 post-4095 productos type-productos status-publish has-post-thumbnail hentry\" data-id=\"4095\">\n\t\t<div class=\"w-grid-item-h\">\n\t\t\t\t\t\t\t<a class=\"w-grid-item-anchor\" href=\"https:\/\/med.labolife.com\/de\/productos\/rantes-27ch\/\" rel=\"bookmark\" aria-label=\"RANTES 27CH\"><\/a>\n\t\t\t\t\t\t<div class=\"w-hwrapper usg_hwrapper_1 us_animate_this align_left valign_top\" style=\"--hwrapper-gap:1.20rem\"><div class=\"w-post-elm post_image usg_post_image_1 stretched\"><a href=\"https:\/\/med.labolife.com\/de\/productos\/rantes-27ch\/\" aria-label=\"RANTES 27CH\"><img loading=\"lazy\" decoding=\"async\" width=\"245\" height=\"160\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2024\/02\/3304425_LLB_RANTES-5CH_2023-gen1-245x160.jpeg\" class=\"attachment-us_245_160_crop size-us_245_160_crop wp-post-image\" alt=\"\" \/><\/a><\/div><div class=\"w-vwrapper usg_vwrapper_1 align_none valign_top\"><div class=\"w-post-elm post_content usg_post_content_1 with_collapsible_content\" data-content-height=\"100px\"><div><div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>1507 UH 150 F33 \u2013 CNK 3304-425<\/p>\n<p>RANTES 27CH<\/p>\n<div class=\"page\" title=\"Page 80\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Tra\u0308gersubstanz: Saccharose pro Gelatinekapsel<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"toggle-links align_none\"><button class=\"collapsible-content-more\"><\/button><button class=\"collapsible-content-less\"><\/button><\/div><\/div><\/div><\/div>\t\t<\/div>\n\t<\/article>\n<\/div><div class=\"w-grid-preloader\"><div class=\"g-preloader type_custom\">\n\t<div><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"273\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue.png 983w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-150x136.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-70x64.png 70w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div>\n<\/div>\n<\/div>\t<div class=\"w-grid-json hidden\" onclick='return {&quot;action&quot;:&quot;us_ajax_grid&quot;,&quot;ajax_url&quot;:&quot;https:\\\/\\\/med.labolife.com\\\/wp-admin\\\/admin-ajax.php&quot;,&quot;infinite_scroll&quot;:0,&quot;max_num_pages&quot;:1,&quot;pagination&quot;:&quot;infinite&quot;,&quot;permalink_url&quot;:&quot;https:\\\/\\\/med.labolife.com\\\/de\\\/wp-json\\\/wp\\\/v2\\\/pages\\\/1382\\\/&quot;,&quot;template_vars&quot;:{&quot;columns&quot;:&quot;2&quot;,&quot;exclude_items&quot;:&quot;none&quot;,&quot;img_size&quot;:&quot;default&quot;,&quot;ignore_items_size&quot;:0,&quot;items_layout&quot;:&quot;677&quot;,&quot;items_offset&quot;:&quot;1&quot;,&quot;load_animation&quot;:&quot;none&quot;,&quot;overriding_link&quot;:&quot;popup_post&quot;,&quot;post_id&quot;:1382,&quot;query_args&quot;:{&quot;post_type&quot;:[&quot;productos&quot;],&quot;post_status&quot;:[&quot;publish&quot;,&quot;acf-disabled&quot;],&quot;posts_per_page&quot;:&quot;53&quot;},&quot;orderby_query_args&quot;:{&quot;orderby&quot;:{&quot;title&quot;:&quot;ASC&quot;},&quot;order&quot;:&quot;ASC&quot;},&quot;type&quot;:&quot;grid&quot;,&quot;us_grid_ajax_index&quot;:1,&quot;us_grid_filter_params&quot;:null,&quot;us_grid_index&quot;:1,&quot;_us_grid_post_type&quot;:&quot;productos&quot;,&quot;lang&quot;:&quot;de&quot;}}'><\/div>\n\t\t<div class=\"l-popup\">\n\t\t<div class=\"l-popup-overlay\"><\/div>\n\t\t<div class=\"l-popup-wrap\">\n\t\t\t<div class=\"l-popup-box\">\n\t\t\t\t<div class=\"l-popup-box-content\">\n\t\t\t\t\t<div class=\"g-preloader type_custom\">\n\t\t\t\t\t\t<div><img loading=\"lazy\" decoding=\"async\" width=\"300\" height=\"273\" src=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png\" class=\"attachment-medium size-medium\" alt=\"\" srcset=\"https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-300x273.png 300w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue.png 983w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-150x136.png 150w, https:\/\/med.labolife.com\/wp-content\/uploads\/2022\/09\/Symbol_Labo_life_Blue-70x64.png 70w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t<iframe class=\"l-popup-box-content-frame\" allowfullscreen><\/iframe>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"l-popup-arrow to_next\" title=\"Weiter\"><\/div>\n\t\t\t\t<div class=\"l-popup-arrow to_prev\" title=\"Zur\u00fcck\"><\/div>\n\t\t\t\t\t\t<div class=\"l-popup-closer\"><\/div>\n\t\t<\/div>\n\t<\/div>\n\t<\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"1507 UH 150 F33 \u2013 CNK 3304-425 RANTES 27CH Tra\u0308gersubstanz: Saccharose pro Gelatinekapsel","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"content-type":"","footnotes":""},"class_list":["post-1382","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/pages\/1382","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/comments?post=1382"}],"version-history":[{"count":24,"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/pages\/1382\/revisions"}],"predecessor-version":[{"id":5607,"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/pages\/1382\/revisions\/5607"}],"wp:attachment":[{"href":"https:\/\/med.labolife.com\/de\/wp-json\/wp\/v2\/media?parent=1382"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}